[PDF][PDF] Clinical manifestations and outcomes of patients with sarcomatoid hepatocellular carcinoma

SH Liao, TH Su, YM Jeng, PC Liang, DS Chen… - …, 2019 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the fifth most common cancer and the second leading
cause of cancer‐related deaths worldwide. Sarcomatoid HCC is a rare histological subtype …

[HTML][HTML] Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for China

Q Xie, JW Xuan, H Tang, XG Ye, P Xu… - World Journal of …, 2019 - ncbi.nlm.nih.gov
About 10 million people in China are infected with hepatitis C virus (HCV), with the
seroprevalence of anti-HCV in the general population estimated at 0.6%. Delaying effective …

Intracellular accumulation of IFN-λ4 induces ER stress and results in anti-cirrhotic but pro-HCV effects

OO Onabajo, F Wang, MH Lee… - Frontiers in …, 2021 - frontiersin.org
IFNL3/IFNL4 polymorphisms are inversely associated with the risk of chronic hepatitis C
virus (HCV) infection and cirrhosis, two major risk factors for developing hepatocellular …

Epidemiology of virus infection and human cancer

CJ Chen, SL You, WL Hsu, HI Yang, MH Lee… - Viruses and human …, 2021 - Springer
Seven viruses including the Epstein–Barr virus (EBV), hepatitis B virus (HBV), hepatitis C
virus (HCV), Kaposi's sarcoma herpes virus (KSHV), human immunodeficiency virus, type-1 …

Cost effectiveness of daclatasvir plus asunaprevir therapy for Chinese patients with chronic hepatitis C virus genotype 1b

Y Liu, Z Wang, RG Tobe, H Lin, B Wu - Clinical Drug Investigation, 2018 - Springer
Abstract Background and Objectives Daclatasvir plus asunaprevir has shown superior
efficacy and safety for treating hepatitis C virus genotype 1b infection in comparison with …

Liver fibrosis regression correlates with downregulation in liver angiogenesis in chronic hepatitis C through viral eradication

SH Chen, CL Huang, IP Chiang… - European Journal of …, 2021 - journals.lww.com
Objectives The impact of viral eradication on hepatic angiogenesis is unknown. This study
aimed to analyze the correlations of liver angiogenesis with liver fibrosis progression or …

Cost-effectiveness analysis of pan-genotypic sofosbuvir-based regimens for treatment of chronic hepatitis C genotype 1 infection in China

HJ Zhou, J Cao, H Shi, N Naidoo, S Semba… - Frontiers in Public …, 2021 - frontiersin.org
Background: Hepatitis C virus (HCV) genotype 1 is the most prevalent HCV infection in
China. Sofosbuvir-based direct antiviral agent (DAA) regimens are the current mainstays of …

Cost-effectiveness of novel regimens for Chinese patients with chronic hepatitis C

B Wu, Z Wang, Q Xie - Current Medical Research and Opinion, 2019 - Taylor & Francis
Objective: Direct-acting antiviral agents (DAAs) have been approved for treating hepatitis C
virus (HCV) infection in China. However, they are substantially more expensive. The current …

Combined Liver Stiffness and Α‐fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long‐Term Liver‐Related Events in Patients with …

SH Chen, HC Lai, WP Su, JT Kao… - Canadian Journal of …, 2022 - Wiley Online Library
Aims. Long‐term risk stratification using combined liver stiffness (LS) and clinically relevant
blood tests acquired at the baseline further beyond the sustained virologic response (SVR) …

Genetic variants associated with serum alanine aminotransferase levels among patients with hepatitis C virus infection: A genome‐wide association study

PC Liu, C Chan, YH Huang, YJ Chen… - Journal of Viral …, 2021 - Wiley Online Library
Abstract Information on genetic variants associated with elevated serum alanine
aminotransferase (ALT) levels remains limited. A genome‐wide association study was …